
Conference title: FROM STANDARDS TO INNOVATION – MODERN DIAGNOSTICS AND TREATMENT OF RECTAL CANCER
Date: Friday, November 28, 2025
Location: Military Institute of Medicine – National Research Institute, Szaserów Street 128, Warsaw
Registration: Registration via the conference organizer's registration form
Event website: konferencje.90c.pl/wim-rakodbytnicy
Organizer: 90 Consulting
Chairwoman of the Scientific Committee: Prof. Renata Duchnowska, Ph.D., M.D., Military Institute of Medicine – State Research Institute of the Central Clinical Hospital of the Ministry of National Defence
Scientific Committee:
Justyna Chałubińska-Fendler, MD, PhD
Piotr Królikowski, MD, PhD
Dr. Andrzej Kwiatkowski, MD • Dr. Kinga Sikorska-Mali
Dr. Wojciech Solarek, MD • Dr. Katarzyna Jarosz-Stachura
CONFERENCE PROGRAMME
10:30 – 10:40 Official opening of the conference, welcoming guests
Prof. Ph.D. med. Renata Duchnowska
SESSION I (sponsored)
From standards to innovation – systemic treatment in the treatment of metastatic rectal and colon cancer. Chair: Jan Korniluk, MD, PhD
10:40-10:55 – Treatment of advanced colorectal cancer – from anti-EGFR therapy to radical treatment. Case study of a patient qualified for liver transplantation, Dr. Agata Kuchar
10:55-11:10 – Molecularly targeted therapy in the treatment of colorectal cancer – the place of anti-EGFR drugs in the era of anti-BRAF and anti-KRAS targeted therapy Dr. Szymon Borowiec
11:10-11:25 – Treatment of 3rd and subsequent lines of advanced colorectal cancer – current therapeutic options Dr. Anna Budzińska
11:25-11:40 – Immunotherapy in patients with MSI-H/dMMR colorectal cancer – new perspectives of treatment in perioperative and advanced stages, Wojciech Solarek, MD, PhD
11:40-11:50 – Panel discussion and questions
11:50 – 12:05 – Coffee break
SESSION II
Diagnosis of locally advanced rectal cancer
Chairman: Prof. Ph.D. med. Renata Duchnowska
12:05-12:20 – The role of endoscopy in the diagnosis of rectal cancer, Piotr Królikowski, MD, PhD
12:20-12:35 – Pathomorphological diagnostics and important molecular tests in rectal cancer, Dr. Kinga Sikorska-Mari
12:35-12:50 – Radiological assessment of local advancement and the presence of metastases – a practical approach to qualification with the special role of MRI examination, Dr. Katarzyna Jarosz-Stachura
12:50-13:00 – Panel discussion and questions
13:00 – 13:15 – Coffee break
SESSION III
Preoperative therapy and modern surgical treatment
Chairman: Wojciech Solarek, MD, PhD
13:15-13:30 – The role of the multidisciplinary team (MDT) in treatment optimization, prof. dr hab. med. Renata Duchnowska
13:30-13:45 – Preoperative radiotherapy: CRT vs SCRT – selection criteria, decision-making algorithms, Justyna Chałubińska-Fendler, MD, PhD
13:45-14:00 – Total Neoadjuvant Therapy (TNT) – what is it and who should it be dedicated to in the light of the new ESMO recommendations?, Dr. Wojciech Solarek, MD
14:00-14:15 – Sequence optimization: when to proceed with surgery and when to proceed with preoperative intensification from the surgeon’s perspective, Andrzej Kwiatkowski, MD, PhD
14:15-14:30 – Surgical techniques including TME and modern laparoscopic and robotic methods, Andrzej Kwiatkowski, MD, PhD
14:30-14:45 – Adjuvant treatment of rectal cancer after radical surgery, Dr. Jan Korniluk, MD
14:45-15:00 – Panel discussion and questions
15:00 – Lunch / end of the conference
